ROS1 Fusions Rarely Overlap with Other Oncogenic Drivers in Non–Small Cell Lung Cancer-Reference-Cited by-同舟云学术

ROS1 Fusions Rarely Overlap with Other Oncogenic Drivers in Non–Small Cell Lung Cancer

Published:2017-05 Issue:5 Volume:12 Page:872-877
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Lin Jessica J.^ORCID,Ritterhouse Lauren L.,Ali Siraj M.,Bailey Mark,Schrock Alexa B.,Gainor Justin F.,Ferris Lorin A.,Mino-Kenudson Mari,Miller Vincent A.,Iafrate Anthony J.,Lennerz Jochen K.,Shaw Alice T.

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference23 articles.

1. Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer;Rikova;Cell,2007

2. ROS1 rearrangements define a unique molecular class of lung cancers;Bergethon;J Clin Oncol,2012

3. New and emerging targeted treatments in advanced non-small-cell lung cancer;Hirsch;Lancet,2016

4. RET, ROS1 and ALK fusions in lung cancer;Takeuchi;Nat Med,2012

5. Preclinical rationale for use of the clinically available multitargeted tyrosine kinase inhibitor crizotinib in ROS1-translocated lung cancer;Yasuda;J Thorac Oncol,2012

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ROS1-rearranged non-small cell lung cancer: Understanding biology and optimizing management in the era of new approvals;Current Problems in Cancer;2024-12

2. Advances and future directions in ROS1 fusion-positive lung cancer;The Oncologist;2024-08-23

3. Lung Adenocarcinoma Systems Biomarker and Drug Candidates Identified by Machine Learning, Gene Expression Data, and Integrative Bioinformatics Pipeline;OMICS: A Journal of Integrative Biology;2024-08-01

4. Concomitant epidermal growth factor receptor mutation/c-ros oncogene 1 rearrangement in non-small cell lung cancer: A case report;World Journal of Clinical Oncology;2024-07-24

5. Importance of Testing for ROS1 Rearrangements in Non-Small Cell Lung Cancer in the Era of Targeted Therapy in a Latin American Country;Cancer Management and Research;2024-07